Latest Breaking News On - Zogenix inc - Page 7 : comparemela.com

Adamis Pharmaceuticals (ADMP) Appoints Vickie Reed to its Board

Fenfluramine found effective in preventing drop seizures from LGS

Phase III trial shows fenfluramine as an adjunct treatment is effective in reducing the frequency of drop seizures from Lennox-Gastaut Syndrome (LGS).

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)

Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizures in LGS.

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)

Primary endpoint was met demonstrating that FINTEPLA, as adjunctive treatment, is effective in significantly reducing the frequency of drop seizur.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026

/PRNewswire/ The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added to ResearchAndMarkets.com s.